{"schema_version":"secwatch.filing_event.v1","accession":"0001564590-22-039439","form_type":"8-K","ticker":"STAA","cik":"0000718937","company_name":"STAAR SURGICAL CO","filed_at":"2022-12-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:53.345699+00:00","generated_at":"2026-06-21T02:56:05.433375+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"CEO transition: Caren Mason retires, Tom Frinzi appointed; Q4 net sales guidance $64M-$66M","bullets":["CEO Caren Mason retires Dec 31, 2022; Board Chair Tom Frinzi becomes CEO effective Jan 1, 2023.","Mason to serve as advisor through Dec 2023 at $100k/month and eligible for 2022 cash bonus.","Frinzi receives $820k base salary, 105% target bonus, and $9M initial equity grant (options & RSUs).","Board reduces to 6 members; Stephen Farrell named Lead Independent Director effective Jan 1, 2023.","Company expects Q4 2022 net sales in the range of $64M to $66M."],"urls":{"canonical":"https://secwatch.observer/filing/0001564590-22-039439","json":"https://secwatch.observer/filing/0001564590-22-039439.json","markdown":"https://secwatch.observer/filing/0001564590-22-039439.md","text":"https://secwatch.observer/filing/0001564590-22-039439.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/718937/000156459022039439/0001564590-22-039439-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/718937/000156459022039439/staa-8k_20221216.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T02:56:05.433375+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1d71996451","claim":"Caren Mason retired as President and Chief Executive Officer at STAAR SURGICAL CO.","evidence_excerpt":"Ms. Caren Mason, President and Chief Executive Officer of the Company, has elected to retire as CEO and a member of the Company’s Board of Directors (the “Board”), effective December 31, 2022","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/718937/000156459022039439/0001564590-22-039439-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"retired"},{"label":"Role","value":"President and Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"8218437e74","claim":"Thomas G. Frinzi was appointed as Chief Executive Officer at STAAR SURGICAL CO.","evidence_excerpt":"the Company announced that the Board elected Thomas G. Frinzi, currently Chair of the Board, to succeed Ms. Mason as CEO, effective January 1, 2023","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/718937/000156459022039439/0001564590-22-039439-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"a6ecb8389c","claim":"Stephen Farrell was appointed as Lead Independent Director at STAAR SURGICAL CO.","evidence_excerpt":"the Board announced creation of the role of Lead Independent Director and appointed Mr. Stephen Farrell, Chair of the Audit Committee, to serve in that capacity","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/718937/000156459022039439/0001564590-22-039439-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Lead Independent Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}